Format
Sort by
Items per page

Send to

Choose Destination

Best matches for pharmacogenetics human cyp:

Cytochrome P450 Structure, Function and Clinical Significance: A Review. Manikandan P et al. Curr Drug Targets. (2018)

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Stout SM et al. Drug Metab Rev. (2014)

Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Miotto K et al. Anesth Analg. (2017)

Search results

Items: 1 to 20 of 603

1.

Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.

Bernasconi C, Pelkonen O, Andersson TB, Strickland J, Wilk-Zasadna I, Asturiol D, Cole T, Liska R, Worth A, Müller-Vieira U, Richert L, Chesne C, Coecke S.

Toxicol In Vitro. 2019 Oct;60:212-228. doi: 10.1016/j.tiv.2019.05.019. Epub 2019 May 31.

2.

Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K1.

Park JW, Kim KA, Park JY.

J Clin Pharmacol. 2019 Nov;59(11):1453-1461. doi: 10.1002/jcph.1444. Epub 2019 May 28.

PMID:
31134657
3.

Optimising migraine treatment: from drug-drug interactions to personalized medicine.

Pomes LM, Guglielmetti M, Bertamino E, Simmaco M, Borro M, Martelletti P.

J Headache Pain. 2019 May 17;20(1):56. doi: 10.1186/s10194-019-1010-3. Review.

4.

Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.

Peko SM, Ntoumi F, Vouvoungui C, Nderu D, Kobawila SC, Velavan TP, Koukouikila-Koussounda F.

Int J Infect Dis. 2019 Aug;85:49-53. doi: 10.1016/j.ijid.2019.04.035. Epub 2019 May 9.

5.

High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis.

Kirbs C, Kluwe F, Drescher F, Lackner E, Matzneller P, Weiss J, Zeitlinger M, Kloft C.

Eur J Pharm Sci. 2019 Apr 1;131:218-229. doi: 10.1016/j.ejps.2019.02.001. Epub 2019 Feb 4.

PMID:
30731238
6.

Ethnopharmacology.

Taylor DM, Werneke U.

Nord J Psychiatry. 2018 Sep;72(sup1):S30-S32. doi: 10.1080/08039488.2018.1525636. Review.

PMID:
30688173
7.

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis.

Richardson M, Kirkham J, Dwan K, Sloan DJ, Davies G, Jorgensen AL.

Syst Rev. 2018 Nov 20;7(1):204. doi: 10.1186/s13643-018-0861-z.

8.

Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin.

Tuteja S, Qu L, Vujkovic M, Dunbar RL, Chen J, DerOhannessian S, Rader DJ.

J Am Heart Assoc. 2018 Oct 2;7(19):e03488. doi: 10.1161/JAHA.117.008461.

9.

Pharmacogenetic considerations for migraine therapies.

Capi M, Gentile G, Lionetto L, Salerno G, Cipolla F, Curto M, Borro M, Martelletti P.

Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1161-1167. doi: 10.1080/17425255.2018.1541452. Epub 2018 Nov 1. Review.

PMID:
30362834
10.

CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor.

Zhu J, Wang P, Li F, Lu J, Shehu AI, Xie W, McMahon D, Ma X.

Biochem Pharmacol. 2018 Dec;158:174-184. doi: 10.1016/j.bcp.2018.10.012. Epub 2018 Oct 17.

PMID:
30342022
11.

Inflammation is a potential risk factor of voriconazole overdose in hematological patients.

Gautier-Veyret E, Truffot A, Bailly S, Fonrose X, Thiebaut-Bertrand A, Tonini J, Cahn JY, Stanke-Labesque F.

Fundam Clin Pharmacol. 2019 Apr;33(2):232-238. doi: 10.1111/fcp.12422. Epub 2018 Dec 7.

PMID:
30306637
12.

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.

Saiz-Rodríguez M, Ochoa D, Herrador C, Belmonte C, Román M, Alday E, Koller D, Zubiaur P, Mejía G, Hernández-Martínez M, Abad-Santos F.

Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):321-329. doi: 10.1111/bcpt.13141. Epub 2018 Oct 30.

PMID:
30281924
13.

HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.

Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH.

Clin Pharmacol Ther. 2019 Feb;105(2):476-485. doi: 10.1002/cpt.1190. Epub 2018 Sep 30.

PMID:
30270535
14.

Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro.

San SN, Matsumoto J, Saito Y, Koike M, Sakaue H, Kato Y, Fujiyoshi M, Ariyoshi N, Yamada H.

Xenobiotica. 2019 Aug;49(8):935-944. doi: 10.1080/00498254.2018.1524947. Epub 2018 Nov 8.

PMID:
30227770
15.

Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients.

Sim S, Bergh J, Hellström M, Hatschek T, Xie H.

Pharmacogenomics. 2018 Nov;19(16):1259-1268. doi: 10.2217/pgs-2018-0080. Epub 2018 Sep 10.

PMID:
30196760
16.

Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A.

Sun JY, Xu ZJ, Sun F, Guo HL, Ding XS, Chen F, Xu J.

Curr Pharm Des. 2018;24(24):2765-2773. doi: 10.2174/1381612824666180829101836. Review.

PMID:
30156148
17.

Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.

Bedada W, de Andrés F, Engidawork E, Hussein J, LLerena A, Aklillu E.

Sci Rep. 2018 Aug 24;8(1):12726. doi: 10.1038/s41598-018-31191-1.

18.

Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

Elfaki I, Mir R, Almutairi FM, Duhier FMA.

Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070. Review.

19.

Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.

Zhou Y, Lauschke VM.

J Med Genet. 2018 Sep;55(9):617-627. doi: 10.1136/jmedgenet-2018-105429. Epub 2018 Jul 3.

PMID:
29970487
20.

Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.

Kvist AJ, Kanebratt KP, Walentinsson A, Palmgren H, O'Hara M, Björkbom A, Andersson LC, Ahlqvist M, Andersson TB.

Biochem Pharmacol. 2018 Sep;155:124-140. doi: 10.1016/j.bcp.2018.06.026. Epub 2018 Jun 25.

PMID:
29953844

Supplemental Content

Loading ...
Support Center